Bio-Rad Laboratories, Inc. (NYSE:BIO) Investor Seeks Access to Company Records over $55 Million Settlement
An investor in Bio-Rad Laboratories, Inc. (NYSE:BIO) filed a petition in effort to get access to certain company records over a $55 million FCPA settlement.
View full press release